Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and De-listing, vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017, and 20190207-23 dated 07 Feb 2019 has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.
All Market Participants are hereby informed that J.B. Chemicals & Pharmaceuticals Limited (the ‘’Company”), has announced Cash offer to Buyback up to 29,54,545 (Twenty-Nine Lakhs Fifty Four Thousand Five Hundred Forty Five) fully paid-up equity shares of the Company of face value of Rs. 2 each (“Equity Share(s)”) from all the shareholders holding Equity Shares / beneficial owners of Equity Shares of the Company, as on the Record Date i.e., Friday, November 22, 2019 (“Record Date”), on a proportionate basis, through the Tender Offer Route using Stock Exchange mechanism (“Tender Offer”), at a price of Rs. 440/- (Rupees Four Hundred Forty Only) per Equity Share (“Buy-back Price”) for an aggregate amount not exceeding Rs. 130 Crores (Rupees One Hundred Thirty Crores only) (“Buy-back Size”), from December 16, 2019 to December 30, 2019.
Market participants are further requested to note that this offer will be as per the Revised Guidelines of SEBI circular no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016 and Exchange notice no. 20170210-16 dated Feb 10, 2017 and the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.
Bhushan Mokashi
Additional General Manager
Listing Sales & Ops
December 12,2019
|